Giulia Simini: Acquired von Willebrand Syndrome and Coagulation Abnormalities in MPN-Associated Thrombocytosis
Giulia Simini, Resident doctor in Hematology at NHS England, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Just published on RPTH!
Acquired von Willebrand syndrome is a often underdiagnosed and misdiagnosed complication of MPNs.
In this cohort of MPN patients with thrombocytosis, 33 percent developed bleeding complications.
However, platelets count alone was not a predictor of bleeding risk.
Interestingly, we found a significant correlation between vWF:RCo/Ag ratio and PT, as well as APTT.
This potentially suggests other coagulation imbalances in patients with MPNs.
One patient was found to have FV deficiency and dysfibrinogenemia.
A tailored approach is essential to assess bleeding risk in this cohort.”
Title: Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center
Authors: Giulia Simini, Andrew Innes, Saravanan Vinayagam, Golzar Mobayen, Nilanthi Karawitage, Simone Claudiani, Zain Odho, Mike Laffan, Deepa J. Arachchillage
Read the Full Article on RPTH.

Other posts featuring Giulia Simini on Hemostasis Today.
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy
-
Jul 9, 2026, 18:21Martin Vanden Eede: Can We Safely Reduce Anticoagulation During ECMO?
-
Jul 9, 2026, 18:00Dorothée Faille: Discovering Versailles During ISTH 2026
-
Jul 9, 2026, 16:45Rutbaa Ayaz Shaikh: One Step Further in Medical Research
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock